UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Herbalife Ltd. (NYSE:HLF – Free Report) by 72.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 168,209 shares of the company’s stock after acquiring an additional 70,498 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.17% of Herbalife worth $1,209,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. nVerses Capital LLC raised its holdings in Herbalife by 240.0% in the second quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock worth $53,000 after purchasing an additional 3,600 shares in the last quarter. Carolina Wealth Advisors LLC bought a new stake in Herbalife in the third quarter worth $78,000. Van ECK Associates Corp grew its stake in shares of Herbalife by 10.3% in the second quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock worth $90,000 after acquiring an additional 808 shares during the last quarter. Prospera Financial Services Inc bought a new position in shares of Herbalife during the third quarter valued at $154,000. Finally, Intech Investment Management LLC purchased a new position in shares of Herbalife in the 3rd quarter worth about $199,000.
Herbalife Stock Performance
Shares of Herbalife stock opened at $7.12 on Wednesday. The company has a market capitalization of $717.14 million, a PE ratio of 8.44, a P/E/G ratio of 0.27 and a beta of 1.17. Herbalife Ltd. has a one year low of $6.59 and a one year high of $15.66. The company has a 50-day simple moving average of $7.65 and a two-hundred day simple moving average of $8.86.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. Citigroup reduced their price objective on shares of Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Friday, October 25th. B. Riley decreased their price target on Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, October 31st. DA Davidson cut their target price on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating for the company in a research report on Thursday, October 31st. Mizuho raised their target price on Herbalife from $8.00 to $9.00 and gave the stock a “neutral” rating in a research report on Friday, November 1st. Finally, StockNews.com upgraded Herbalife from a “hold” rating to a “buy” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $9.90.
Check Out Our Latest Analysis on Herbalife
Herbalife Company Profile
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Further Reading
- Five stocks we like better than Herbalife
- EV Stocks and How to Profit from Them
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How Can Investors Benefit From After-Hours Trading
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Retail Stocks Investing, Explained
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.